Welcome to GeneTherapy.com
Home | Archive | Contact Us | FAQ | Forum | Recommend Us | Submit | Registration/Login


Login
Nickname

Password

Don't have an account yet? You can create one. As a registered user you have some advantages like theme manager, comments configuration and post comments with your name.

Sponsors
DNA Vaccine

Aldevron LLC

World Vaccine

ichor


  
GeneTherapy.com is powered by user submissions. So please join the community and submit a story today!

How to fortify the immunity of HIV patients
Syndicated from ScienceDaily.com on Tue, 09 Mar 2010 17:00:00 EST

New findings may soon lead to an expansion of the drug arsenal used to fight HIV.


Genetic cause discovered for rare bleeding disorder
Syndicated from ScienceDaily.com on Mon, 08 Mar 2010 17:00:00 EST

Hematologists have discovered the genetic cause of Quebec platelet disorder. They have gone on to develop a genetic test for the condition -- a major advance in diagnosing this serious and unusual bleeding problem.


Immunology: New Gene Mutation Linked To Antibody Deficiency
Syndicated from ScienceDaily.com on Mon, 08 Mar 2010 00:00:00 EST

Individuals who have abnormally low levels of immune molecules known as antibodies have an increased susceptibility to infection with certain types of bacteria. By analyzing one such person, researchers have identified a new genetic cause of antibody deficiency, mutations in the CD81 gene.


Second dose of gene therapy for inherited blindness proves safe in animal studies
Syndicated from ScienceDaily.com on Thu, 04 Mar 2010 14:00:00 EST

A research team that conducted the gene therapy trial for an inherited blindness reports that a study in animals has shown that a second injection of genes into the opposite, previously untreated eye is safe and effective, with no signs of interference from unwanted immune reactions following the earlier injection. These new findings suggest that patients who benefit from gene therapy in one eye may experience similar benefits from treatment in the other eye.


Gene may be among most influential factors in Down syndrome
Syndicated from ScienceDaily.com on Mon, 01 Mar 2010 23:00:00 EST

Research undertaken in recent years on Down syndrome has focused on the DYRK1A gene. The super-expression of this gene affects transmission in the neurons, according to a new study.


 
User Submitted Stories

All content bellow is generated by users like you. Join the community and starting submitting your own articles today.


Same blue dye in M&Ms linked to reducing spine injury
Posted by admin on Tuesday, July 28 @ 14:01:41 PDT (99 reads)

Animal Testing The same blue food dye found in M&Ms and Gatorade could be used to reduce damage caused by spine injuries, offering a better chance of recovery, according to new research.

Researchers at the University of Rochester Medical Center found that when they injected the compound Brilliant Blue G (BBG) into rats suffering spinal cord injuries, the rodents were able to walk again, albeit with a limp.

(Read More... | 4183 bytes more | 2 comments | Score: 0)


Novel Gene Therapy for Brain Tumor Nears Clinical Trial
Posted by admin on Friday, July 24 @ 13:00:00 PDT (54 reads)

Clinical Trials THURSDAY, July 2 (HealthDay News) -- A novel gene therapy for glioblastoma multiforme utilizing a combination of adenoviral vectors and the drug ganciclovir (GCV) is nearing clinical trial with the discovery of a biomarker to gauge tumor response to the treatment, according to a study reported in the July 1 issue of Clinical Cancer Research.

(Read More... | 1955 bytes more | comments? | Score: 0)


Synthetic Biology: Gene Therapy Gets Under The Skin
Posted by admin on Monday, July 20 @ 10:17:40 PDT (53 reads)

General Vaseline, a known molecule from apples and a gene network encapsulated in algal gelatin are the components of a possible gene therapy which literally gets under the skin.

(Read More... | 3810 bytes more | comments? | Score: 0)


Jean Bennett and Albert Maguire: Gene Therapy to Reverse Near-Blindness
Posted by admin on Monday, July 20 @ 09:58:10 PDT (488 reads)

Clinical Trials For Jean Bennett and Albert Maguire, sharing a human brain in a neuroanatomy class stirred up a personal chemistry that produced a marriage and three kids. It led to a 25-year professional partnership as well, a collaboration that has yielded one of the first successful demonstrations of gene therapy in humans. The partners have restored much of the vision in patients who have a rare genetic form of severely impaired eyesight called Leber's congenital amaurosis, in which a mutated gene prevents the retina from manufacturing a nutrient vital to eye health. The technique eventually could be tried to treat macular degeneration.

(Read More... | 3552 bytes more | 85 comments | Score: 1)


Swine flu vaccine made in Europe
Posted by admin on Friday, July 03 @ 07:00:00 PDT (53 reads)

Clinical Trials The first doses of an H1N1 swine flu vaccine have been produced in Europe - but it will be around two months before any is distributed.

The doses were produced by Novartis at a plant in Marburg, Germany.The vaccine was made in cell culture, a much faster method than the traditional way of growing it in eggs.


(Read More... | 3045 bytes more | comments? | Score: 5)


Gene Therapy Could Expand Stem Cells' Promise
Posted by admin on Friday, June 26 @ 13:00:00 PDT (55 reads)

Clinical Trials Once placed into a patient's body, stem cells intended to treat or cure a disease could end up wreaking havoc simply because they are no longer under the control of the clinician.

But gene therapy has the potential to solve this problem, according to a perspective article from physician-scientists at NewYork-Presbyterian Hospital/Weill Cornell Medical Center published in a recent issue of the journal Cell Stem Cell. The paper details strategies for genetically modifying stem cells prior to transplantation in order to ensure their safety.

(Read More... | 3872 bytes more | comments? | Score: 0)


Diseased cells transformed into healthy stem cells
Posted by admin on Monday, June 22 @ 13:00:00 PDT (87 reads)

General Genetically diseased cells that have had their defect corrected through gene therapy can be reprogrammed into stem cells capable of forming any tissue in the body, say researchers.

Although major obstacles remain before gene therapists can use the technique on people, the advance stands as a proof of principle that the marriage of gene therapy and stem-cell technologies have the potential to allow doctors to correct any genetic diseases that cripple a particular type of cell.

Until now, attempts to use gene therapy on stem cells have required therapists to harvest naturally occurring stem cells from patients and apply the gene therapy to them. However, such stem cells are rare, so the harvest yields little material to work with.

(Read More... | 2270 bytes more | 3 comments | Score: 0)


First pig stem cells could make 'humanised' organs
Posted by admin on Friday, June 19 @ 13:00:00 PDT (62 reads)

General The world's first pig stem cells have been created from porcine ear and bone-marrow cells.

Researchers at the Institute of Biochemistry and Cell Biology in Shanghai, China, say they are the first to achieve this in hoofed animals.

Induced pluripotent stem (iPS) cells have the potential to turn into all types of body tissue. The big advantage, though, is that they can be genetically manipulated in the lab, and then cloned to create animals with new traits.

By adding or deleting certain genes, for example, researchers could produce pigs whose organs can be transplanted into patients without them being recognized and rejected. Efforts to do such xenotransplants have already been under way for at least a decade, but iPS cells are easier to genetically engineer and grow in the lab than pig embryos, opening up new possibilities for xenotransplantation.

(Read More... | 2757 bytes more | 2 comments | Score: 0)


Gene therapy shows promise as weapon against HIV
Posted by admin on Monday, June 15 @ 13:00:00 PDT (79 reads)

General
A new UCLA AIDS Institute study has found that gene therapy can be developed as a safe and active technique to combat HIV.
 
Researchers involved in this first-of-its-kind study found that cell-delivered gene transfer has the potential to be a once-only treatment that reduces viral load, preserves the immune system and avoids lifelong antiretroviral therapy. The study appears in the current online edition of the journal Nature Medicine.
 
Though modest, the results do show some promise that gene therapy can be developed as a potentially effective treatment for HIV, said lead investigator Dr. Ronald Mitsuyasu, professor of medicine and director of the Center for Clinical AIDS Research and Education (CARE) at the David Geffen School of Medicine at UCLA.


(Read More... | 4882 bytes more | comments? | Score: 0)


Animal extremists arrested for harassment of campus researchers
Posted by admin on Friday, June 12 @ 13:00:00 PDT (49 reads)

Ethics
Two people have been arrested and charged in connection with the ongoing campaign of harassment of UCLA researchers who utilize laboratory animals in their work.
 
The Los Angeles County district attorney's office announced today that Linda Faith Greene, 61, and Kevin Richard Olliff, 22, entered not guilty pleas after being arraigned on stalking and other felony charges.
 
No arrests have been made in connection with several incidents of arson and attempted arson claimed by anti–animal research extremists targeting UCLA.


(Read More... | 2497 bytes more | comments? | Score: 0)


  
Google News
·Gene Therapy: renewed interest and new discoveries in therapeutic applications - MMD Newswire (press release)
·Scientists Still Hopeful About Gene Therapy's Promise - NPR
·Beyond Biologics: Gene Therapy and Stem Cells for the New Decade - Healthcanal.com
·Fresh hope for HIV patients - Times of India
·Discovery of “Pain Gene” Could Help Control Pain: Researchers - TopNews United States
·Gene Therapy a Step Closer to Restoring Eyesight to Some Blind Patients - Voice of America
·Neurologix to Present at Roth Capital Partners 2010 OC Growth Stock Conference - MarketWatch (press release)
·Ottawa researchers tackle eye diseases in $1.4M project - Ottawa Citizen
·Gene therapy may help treat lethal childhood muscle disorder - Daily News & Analysis
·Gene Therapy Gives Hope in Virulent Form of Cancer - ABC News

read more...

©2009 GeneTherapy.com - Terms of Use | RSS Feed
All logos and trademarks in this site are property of their respective owner. The comments are property of their posters, all the rest ©GeneTherapy.com 2009

PHP-Nuke Copyright © 2005 by Francisco Burzi. This is free software, and you may redistribute it under the GPL. PHP-Nuke comes with absolutely no warranty, for details, see the license.
Page Generation: 1.27 Seconds